DaltonTx is a UK-based technology company specializing in the development of adaptive AI-enabled discovery platforms aimed at transforming drug discovery processes. Their platform integrates seamlessly into pharma, biotech, and CRO workflows, enhancing the economics, timelines, and outcomes of R&D by providing a self-learning system that evolves with each experiment. Purpose-built for both small molecules and biologics, DaltonTx combines world-class science and technology to help teams design, optimize, and deliver breakthrough medicines more efficiently. Founded by experts in drug discovery, machine learning, and software engineering, the company leverages its deep expertise to redefine how technology powers modern drug discovery.